Top Markets
#1 Smilek to the Bank Smilek to the Bank +50.56%
#2 Purr Purr +45.04%
#3 龙虾 (Lobster) 龙虾 (Lobster) +23.45%
#4 DigiByte DigiByte +22.53%
#5 Pons Pons +21.97%
#6 OriginTrail OriginTrail +19.97%
#7 Non-Playable Coin Non-Playable Coin +18.21%
#8 ApeX ApeX +17.96%
#9 Zora Zora +17.33%
#10 Morpho Morpho +16.16%
Coin of the day
Smilek to the Bank Smilek to the Bank
Settings
Language
ENGLISH
Currency
USD
Theme
Apontis Pharma AG Apontis Pharma AG

Apontis Pharma AG

APPH
Rank in Stocks #21489
Operating within Germany, Apontis Pharma AG specializes in the marketing and... Operating within Germany, Apontis Pharma AG specializes in the marketing and distribution of pharmaceutical products, with a particular emphasis on internal medicine. The company is actively involved in the development, promotion, and commercialization of a diverse portfolio, which includes combination single-pill therapies and other medications. Key therapeutic areas of focus encompass cardiovascular diseases, such as high blood pressure (hypertension), elevated cholesterol (hyperlipidemia), and strategies for secondary prevention, in addition to respiratory ailments and diabetes. Established in 1946, Apontis Pharma AG maintains its corporate headquarters in Monheim am Rhein, Germany.
Share Price
$12.75
Last synced: 2025-11-17
Market Cap
$106.20M
Change (1 day)
-2.29%
Change (1 year)
0.24%
Country
DE
Trade Apontis Pharma AG (APPH)

Category

Healthcare
P/E ratio for Apontis Pharma AG (APPH)
P/E ratio as of 2026 TTM: 0
According to Apontis Pharma AG latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Apontis Pharma AG from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 38.29 -
IN
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.